[Cefoxitin and ESBL].
暂无分享,去创建一个
K. Faure | R. Dessein | B. Guery | A. Bignon | M. Boyer | Eric Kipnis
[1] J. Pitout. Infections with Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae , 2010, Drugs.
[2] Pierre Luisoni. Editorial and Introduction to the Open File , 2006 .
[3] C. Sanders,et al. Emergence of resistance in gram-negative bacteria during therapy with expanded-spectrum cephalosporins , 1987, European Journal of Clinical Microbiology.
[4] C. Bizet,et al. In vivo selection of a cephamycin-resistant, porin-deficient mutant of Klebsiella pneumoniae producing a TEM-3 beta-lactamase. , 1989, The Journal of infectious diseases.
[5] V. Moritz,et al. Cefoxitin sensitivity as a marker for inducible beta-lactamases. , 1986, Journal of medical microbiology.
[6] P. McDonald,et al. Use of peroperative cefoxitin to prevent infection after colonic and rectal surgery. , 1981, Annals of surgery.
[7] C. Sanders,et al. Emergence of Resistance to Cefamandole: Possible Role of Cefoxitin-Inducible Beta-Lactamases , 1979, Antimicrobial Agents and Chemotherapy.
[8] H. Neu. Comparative studies of cefoxitin and cephalothin: an overview. , 1979, Reviews of infectious diseases.
[9] J. Kosmidis,et al. Cefoxitin and Cephalothin: Antimicrobial Activity, Human Pharmacokinetics, and Toxicology , 1974, Antimicrobial Agents and Chemotherapy.